Skip navigation

Mallinckrodt Inc.

Pharmaceuticals
USA
Revenue (US$ Millions)$2,581
Revenue Growth (%)-88%
Net Income (US$ Millions)$173
Earnings Per Share (US$)$2.40
Total Equity (US$ Millions)$1,049
Profit Margin (%)6.70%
Debt To Equity Ratio (%)0.71%